The linker, on the other hand, maintains the peptide mask close to the active site and it is cleavable by proteases that are active in the TME, such as tumor-associated serine protease matriptase (MT-SP1) and urokinase plasminogen activator (uPA) [3]. The gene discussed is PLAU; the disease is neoplasm.